Breaking Down Yueyang Xingchang Petro-Chemical Co., Ltd. Financial Health: Key Insights for Investors

CN | Basic Materials | Chemicals | SHZ

Yueyang Xingchang Petro-Chemical Co., Ltd. (000819.SZ) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Yueyang Xingchang Petro-Chemical's recent financial trajectory demands a close look: revenue rose to 3.82 billion yuan in 2024 (+24.62% YoY) but slid to 1.529 billion yuan in H1 2025 (-19.17% YoY), while 2024 net income fell to 63.13 million yuan (-37.55% YoY) and Q1 2025 net income was only 13.6081 million yuan (-37.00% YoY); profitability metrics show a troubling shift with the net profit margin turning from 2.59% in H1 2024 to -1.98% in H1 2025 and ROE at -1.79% (TTM), gross profit margin still solid at 28% in 2023 driven by a 3.0 billion yuan polyethylene segment contribution, yet liquidity and solvency flags include a current ratio of 1.15, quick ratio 0.55, operating cash flow of -104 million yuan in H1 2025, debt-to-equity 27.64% with total debt 620.47 million yuan against cash 300.85 million, debt/EBITDA at 5.74 and EV/EBITDA at 68.82, while valuation metrics (P/S 1.98, P/B 3.12, market cap 7.00 billion, EV 7.44 billion) and a low beta of 0.41 contrast with negative free cash flow (EV/FCF -19.09) - read on to unpack these figures, the risk signals (interest coverage -1.37, inventory days 28.64, negative ROA -0.29, ROIC -0.34) and the growth levers such as an 83.74% annual rise in R&D spend (2021-2024) and a rising R&D headcount as the company pivots toward high-end new materials and clean energy.

Yueyang Xingchang Petro-Chemical Co., Ltd. (000819.SZ) Revenue Analysis

  • 2024 total revenue: 3.82 billion yuan, up 24.62% from 3.07 billion yuan in 2023.
  • First half 2025 revenue: 1.529 billion yuan, down 19.17% year-on-year.
  • Polyethylene contribution (2023): 3.0 billion yuan of total revenue.
  • Gross profit margin (2023): 28.0%, indicating relatively strong operational efficiency for that year.
  • Q1 2025 net income: 13.6081 million yuan, a year-on-year decrease of 37.00%.
  • Net profit margin: fell from 2.59% in H1 2024 to -1.98% in H1 2025, a decrease of 4.57 percentage points.
Period Revenue (CNY) YoY Change Gross Profit Margin Net Income (CNY) Net Profit Margin
2023 (FY) 3.07 billion - 28.0% - -
2024 (FY) 3.82 billion +24.62% - - -
H1 2024 (implied) ~? (basis for margin comparison) - - - 2.59%
H1 2025 1.529 billion -19.17% - - -1.98%
Q1 2025 - - - 13.6081 million -
Polyethylene (2023) 3.00 billion - - - -
  • Revenue mix: polyethylene dominated 2023 revenue, representing the bulk of sales and materially driving the 2024 rebound.
  • Recent trend: sharp H1 2025 revenue contraction (-19.17% YoY) coincides with negative H1 net margin, shifting profitability from modestly positive to negative.
  • Profitability sensitivity: despite a healthy 28% gross margin in 2023, operating/other costs and/or pricing pressure have compressed bottom-line margins into negative territory in H1 2025.
Exploring Yueyang Xingchang Petro-Chemical Co., Ltd. Investor Profile: Who's Buying and Why?

Yueyang Xingchang Petro-Chemical Co., Ltd. (000819.SZ) Profitability Metrics

Key profitability indicators for Yueyang Xingchang Petro-Chemical Co., Ltd. (000819.SZ) show material deterioration through 2024 and into the first half of 2025, with negative returns on capital and slipping margins.

  • Net income (2024): 63.13 million yuan - a decrease of 37.55% vs. prior year (prior year ≈ 101.12 million yuan).
  • ROE (TTM): -1.79%.
  • Gross profit margin: fell from 17.45% to 16.04% (H1 2024 → H1 2025).
  • Net profit margin: turned negative, from 2.59% (H1 2024) to -1.98% (H1 2025).
  • ROA (TTM): -0.29%.
  • ROIC (TTM): -0.34%.
Metric Value Period Comment
Net Income 63.13 million CNY 2024 Down 37.55% vs. 2023 (≈101.12 million CNY in 2023)
Return on Equity (ROE) -1.79% TTM Negative shareholder returns on trailing basis
Gross Profit Margin 16.04% H1 2025 Declined from 17.45% in H1 2024
Net Profit Margin -1.98% H1 2025 Was 2.59% in H1 2024 - turned negative
Return on Assets (ROA) -0.29% TTM Assets generating negative net returns
Return on Invested Capital (ROIC) -0.34% TTM Negative returns after operating and capital costs

For broader context on company background, see: Yueyang Xingchang Petro-Chemical Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

Yueyang Xingchang Petro-Chemical Co., Ltd. (000819.SZ) - Debt vs. Equity Structure

Yueyang Xingchang Petro-Chemical's capital structure as of September 30, 2025 shows modest recorded liabilities but several coverage and cash-flow metrics that signal stress when compared to earnings.
  • Debt-to-equity ratio: 27.64% - equity still materially larger than recorded debt.
  • Total debt: ¥620.47 million; cash and equivalents: ¥300.85 million; net debt (net cash position): -¥319.62 million (net borrower position of ¥319.62m).
  • Enterprise value: ¥7.44 billion vs. market capitalization: ¥7.00 billion - EV premium of ¥0.44 billion reflecting net debt and minority/other adjustments.
  • Debt/EBITDA: 5.74 - indicates high leverage relative to operating earnings.
  • Debt/free cash flow: -1.59 - negative free cash flow relative to debt outstanding.
  • Interest coverage ratio: -1.37 - operating earnings insufficient to cover interest expense.
Metric Value (¥) Interpretation
Total debt 620,470,000 Recorded interest-bearing liabilities
Cash & equivalents 300,850,000 Available liquidity
Net debt (cash) -319,620,000 Net borrower position (negative = net debt)
Debt-to-equity 27.64% Moderate leverage vs. shareholders' equity
Enterprise value 7,440,000,000 Market cap + net debt
Market capitalization 7,000,000,000 Equity market value
Debt / EBITDA 5.74x High relative leverage
Debt / Free Cash Flow -1.59x Negative FCF - repayment capacity weak
Interest coverage (EBIT / Interest) -1.37x Inability to cover interest from operating earnings
For background on company history, ownership and business model, see Yueyang Xingchang Petro-Chemical Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

Yueyang Xingchang Petro-Chemical Co., Ltd. (000819.SZ) - Liquidity and Solvency

  • Current ratio: 1.15 - ability to cover short-term liabilities with short-term assets is marginally above 1.0.
  • Quick ratio: 0.55 - indicates reliance on inventory to meet immediate obligations; potential short-term liquidity pressure.
  • Net cash flow from operating activities (1H 2025): -104 million yuan, versus +54 million yuan in 1H 2024 - a material deterioration in operating cash generation.
  • Asset-liability ratio (1H 2025): 30.32% - up 9.07 percentage points year-on-year, reflecting higher leverage relative to assets.
  • Cash holdings as of 2025-09-30: 300.74 million yuan - down 22.09% from prior comparable figure.
  • Inventory turnover days: 28.64 days - increased 17.02% versus 1H 2024, implying slower inventory movement.
Metric Value Change YoY / Comment
Current Ratio 1.15 Marginally above 1.0
Quick Ratio 0.55 Below 1.0 - inventory-dependent
Operating Cash Flow (1H 2025) -104 million CNY From +54 million CNY in 1H 2024
Asset-Liability Ratio 30.32% +9.07 ppt YoY
Cash Holdings (2025-09-30) 300.74 million CNY -22.09%
Inventory Turnover Days 28.64 days +17.02% YoY
  • Implications for liquidity management: with a quick ratio of 0.55 and declining cash, the company may need to rely on inventory liquidation, short-term financing, or improved collections to bridge operating shortfalls.
  • Solvency context: asset-liability ratio rising to 30.32% signals increased leverage but remains moderate in absolute terms; monitor trend if operating cash flow remains negative.
  • Operational levers to watch: speed of inventory turn, receivables collection, and capex/working capital discipline to restore positive operating cash flow.
Exploring Yueyang Xingchang Petro-Chemical Co., Ltd. Investor Profile: Who's Buying and Why?

Yueyang Xingchang Petro-Chemical Co., Ltd. (000819.SZ) - Valuation Analysis

Yueyang Xingchang Petro-Chemical's market pricing and multiple profile point to a stock trading at a premium on several traditional valuation measures while showing stress in cash-generation metrics.
  • Market capitalization: ¥7.00 billion; enterprise value: ¥7.44 billion.
  • Price-to-Sales (P/S): 1.98 - roughly ¥1.98 of market value per ¥1 of revenue.
  • Price-to-Book (P/B): 3.12 - the market values the company at slightly more than three times book equity.
  • EV/EBITDA: 68.82 - extremely high relative to typical sector ranges, indicating limited EBITDA relative to enterprise value.
  • EV/FCF: -19.09 - negative free cash flow position producing an EV/FCF ratio below zero.
  • 52-week price change: +5.93% - modest appreciation over one year.
  • Beta: 0.41 - lower volatility versus the market, suggesting defensive price behavior.
Metric Value Implication
Market Capitalization ¥7.00 billion Size reference for equity investors
Enterprise Value (EV) ¥7.44 billion Includes debt and cash adjustments
P/S 1.98 Moderate premium to sales
P/B 3.12 Market prices tangible/net assets at a premium
EV/EBITDA 68.82 Very high - earnings base is small relative to EV
EV/FCF -19.09 Negative FCF - EV divided by negative cash flow
52-Week Price Change +5.93% Moderate positive momentum
Beta 0.41 Lower systematic volatility
Key considerations for investors include the contrast between moderate market cap and sales-based multiples versus stretched EV/EBITDA and negative EV/FCF; such divergence signals potential operational or cash-conversion issues despite a low-beta profile. See further investor context here: Exploring Yueyang Xingchang Petro-Chemical Co., Ltd. Investor Profile: Who's Buying and Why?

Yueyang Xingchang Petro-Chemical Co., Ltd. (000819.SZ) - Risk Factors

The following section highlights material financial and operational risks for Yueyang Xingchang Petro-Chemical Co., Ltd. (000819.SZ), supported by recent reported metrics.
  • Profitability deterioration: net profit margin fell from 2.59% in 1H2024 to -1.98% in 1H2025, indicating a swing to losses on core operations.
  • Negative return on equity: ROE is -1.79% on a TTM basis, signaling capital is generating negative returns for equity holders.
  • Cash-flow stress: net cash flow from operating activities was negative ¥104 million in 1H2025, increasing liquidity and working-capital pressures.
  • Leverage concerns: debt-to-EBITDA ratio at 5.74 reflects elevated indebtedness relative to earnings capacity.
  • Interest-servicing risk: interest coverage ratio is -1.37, meaning operating earnings are insufficient to cover interest expense.
  • Inventory management weakening: inventory turnover days increased to 28.64 days, up 17.02% vs. 1H2024, tying up cash in stock.
Metric Value Period
Net Profit Margin -1.98% 1H2025
Net Profit Margin 2.59% 1H2024
ROE (TTM) -1.79% TTM
Operating Cash Flow ¥-104,000,000 1H2025
Debt / EBITDA 5.74 Latest reported
Interest Coverage Ratio -1.37 Latest reported
Inventory Turnover Days 28.64 days 1H2025
Inventory Turnover Days (YoY change) +17.02% vs 1H2024
  • Implications for investors:
    • Potential need for additional capital or asset sales if cash-flow and interest coverage do not improve.
    • Heightened sensitivity to commodity price swings, margin compression, and working-capital shifts.
    • Credit-rating and refinancing risk given elevated debt/EBITDA and negative interest coverage.
Exploring Yueyang Xingchang Petro-Chemical Co., Ltd. Investor Profile: Who's Buying and Why?

Yueyang Xingchang Petro-Chemical Co., Ltd. (000819.SZ) - Growth Opportunities

Yueyang Xingchang Petro-Chemical Co., Ltd. (000819.SZ) is positioning itself from a traditional petrochemical producer toward high-end new materials and clean energy, underpinned by accelerated R&D investment, workforce realignment, and a concentrated product mix where polyethylene plays a material role.
  • R&D spending accelerated dramatically: R&D expenses grew at an annualized rate of 83.74% from 2021 through 2024, signaling sizable reinvestment into innovation and product development.
  • Talent shift toward innovation: R&D headcount rose from 3.75% to 39.0% of total employees over the same period, reflecting a structural change in human-capital allocation.
  • Revenue concentration in polyethylene: The polyethylene segment generated roughly ¥3.0 billion in revenue in 2023, marking it as a cornerstone of current sales.
  • Strategic commitment refreshed in 2025: Management announced a targeted push into high-end materials with an R&D boost in July 2025 to accelerate commercialization of advanced products.
  • Historical market-cap benchmark: Market capitalization peaked at ¥15.693 billion on May 27, 2015, providing a reference point for long-term value potential.
  • Operational efficiency: Gross profit margin was 28% in 2023, indicating healthy production economics relative to peers.
Metric Value Period / Note
R&D expense CAGR 83.74% p.a. 2021-2024
R&D staff (% of workforce) 3.75% → 39.0% 2021 → 2024
Polyethylene revenue ¥3,000,000,000 2023
Gross profit margin 28% 2023
Market capitalization peak ¥15.693 billion May 27, 2015
Strategic R&D announcement High-end materials focus July 2025
  • Growth vectors to watch:
    • Commercialization of high-end polymer grades and specialty chemicals developed through the intensified R&D pipeline.
    • Scale-up and margin expansion in the polyethylene business, which already contributed ¥3.0 billion in 2023.
    • Opportunities in clean-energy-linked feedstocks and materials (e.g., materials for batteries, composites) as R&D yields new products.
    • Operational leverage: maintain or improve the 28% gross margin while expanding higher-margin specialty output.
Mission Statement, Vision, & Core Values (2026) of Yueyang Xingchang Petro-Chemical Co., Ltd.

DCF model

Yueyang Xingchang Petro-Chemical Co., Ltd. (000819.SZ) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.